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In situ hybridization studies of matrix metalloproteinase3, tissue
inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephrop-
athy. Progressive expansion of the mesangial matrix is one of the most
characteristic histological features of diabetic nephropathy (DN). To
determine the balance between the turnover and degradation of extracel-
lular matrix (ECM) in renal tissue of patients with DN, we examined the
expression of matrix metalloproteinase-3 (MMP-3), tissue inhibitor of
metalloproteinase-1 (TIMP-1) and type IV collagen (IV-C) mRNAs using
a high-resolution in situ hybridization. Patients were divided into three
grades: mild (grade I), moderate (grade II) and severe (grade III)
mesangial expansion and tubulointerstitial injury. The relationship be-
tween the expression of these mRNAs and degree of glomerular mesan-
gial expansion and interstitial injury was also examined. Cells positive for
each mRNA were observed in glomerular resident cells, including glomer-
ular mesangial, epithelial and endothelial cells and cells of Bowman's
capsule. A number of tubular epithelial cells and some infiltrating cells in
the interstitium also expressed these mRNAs. The expression of MMP-3
mRNA and TIMP-1 mRNA was strongest in glomeruli of grade I and
inversely correlated with mesangial expansion. In contrast, the expression
of all three types of mRNA was correlated with the degree of interstitial
injury. Our results indicate that TV-C, MMP-3 and TIMP-1 mRNAs are
expressed in glomerular resident cells, tubular epithelial cells and infil-
trating cells in renal tissue of DN, and suggest that their expression
changes with the degree of mesangial expansion and interstitial injury.
Altered expression of MMP-3 and TIMP-1 may be associated with the
progression of DN.
Diabetic nephropathy (DN) is one of the most important causes
of chronic renal failure. The histological hallmarks of DN both in
insulin-dependent diabetes mellitus (IDDM) and non-insulin-
dependent diabetes mellitus (NIDDM) are increased thickness of
the glomerular basement membrane (GBM) and mesangial ex-
pansion, as previously observed in IDDM [11—41. The latter has
been reported to he the most critical lesion of DN because
glomeruloscierosis and decline in renal function correlate well
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with the degree of mesangial expansion [3]. The pathological
change in mesangial expansion is characterized by an increase in
all intrinsic components of mesangial matrix, such as type IV
(TV-C), V and VI collagens, laminin and fibronectin, as well as
additional components of extracellular matrix (ECM) that have
not been identified in normal glomeruli [5, 6]. In this regard, TV-C
is one of the major components of GBM and mesangial matrix.
Results of in vitro studies indicate that glomerular resident cells,
such as glomerular mesangial cells and epithelial cells, are capable
of producing ECM [7, 8] and that cultured mesangial cells
overproduce TV-C in the presence of high concentration of glu-
cose [9—11]. In the process of ECM expansion, although a balance
between ECM production and degradation is important, these
relationships are not fully understood in DN.
Matrix metalloproteinase-3 (MMP-3), one of the MMPs, de-
grades ECM and has a broad substrate specificity, including TV-C,
laminin, fibronectin and proteoglycans. All these components of
mesangial matrix and GBM are increased in DN [5, 61. Therefore,
in the present study we examined the expression of MMP-3.
Cultured mesangial cells synthesize several types of MMPs [12—
14], and some MMPs are abnormally expressed in certain exper-
imental models [15, 16]. On the other hand, tissue inhibitor of
metalloproteinase-1 (TIMP-1) is known to inhibit the activity of
MMP-3, and the expression of TIMP-1 mRNA in human glomer-
uli was recently described by Carome et al [171. We have recently
reported the expression of MMP-3 mRNA and TIMP-1 mRNA in
IgA nephropathy (IgAN), an immune-mediated glomerulonephri-
tis [18]. In renal biopsy specimens from patients with IgAN,
MMP-3 and TIMP-1 mRNAs were expressed in glomerular
resident cells, tubular epithelial cells and infiltrated mononuclear
cells, and their expression was enhanced in advanced tissue
damage [18]. However, it is not known whether these genes are
expressed in DN, which is known as a non-immune-mediated
renal disease. We postulated that an altered expression of MMP-3
and TIMP-1 may lead to the progression of DN. To examine the
balance between ECM production and degradation in DN, we
performed a high-resolution in situ hybridization, which was
developed in our laboratory [19, 201, using renal tissue samples of
patients with DN. Localization of TV-C mRNA, MMP-3 mRNA
and TTMP-1 mRNA was determined at a cellular level, and the
relationship between their expression and histological changes
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Fig. 1. Light microscopic findings of glomeruli in representative patients of diabetic nephropathy (DN) by PAM staining. We divided patients with DN
into three grades according to the degree of mesangial expansion. (a and b). Grade I. Note the mild degree of mesangial expansion, and also a lack of
tuhulointerstitial changes (a, original magnification x20; h, x200). (c and d). Grade II. Note thickening of glomerular basement membrane (GBM) and
a moderate degree of mesangial expansion (e, x20; d, X200). (e andD. Grade Ill. A photograph demonstrating thickening of GBM, severe mesangial
expansion and nodular lesions. Note also the marked changes in the tubulointerstitium (e, X20; f, X200).
was examined, Our results showed the expression of IV-C, tion of renal biopsy specimens, such as light microscopy, electron
MMP-3 and TIMP-1 mRNAs in glomerular resident cells, tubular microscopy and immunofluorescence staining. All patients had
epithelial cells and infiltrating cells in DN, and that alteration of NIDDM, diagnosed according to the criteria of the Japanese
their expressions was associated with mesangial expansion and Diabetic Society [21]. Based on light microscopy findings, patients
interstitial injury, were divided into three grades: grade I (8 patients) had mild
METHODS mesangial expansion and interstitial injury, grade II (8 patients)had moderate mesangial expansion and interstitial injury, and
Patients grade III (3 patients) had severe mesangial expansion, in which
Renal biopsy specimens were obtained from 19 patients with Kimmelsticl-Wilson nodules and severe interstitial injury were
DN. The presence of DN was confirmed by pathological evalua- often observed (Fig. 1). The study was approved by the Human
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Table 1. Clinical parameters at the time of open renal biopsy
Histological
grade of diabetic
nephropathy
Age
years
Known duration
of diabetes
years
Serum
creatinine
mg/dl
HbAlc
%
Urinary
protein
giday
Creatinine
clearance
mi/mm
I 36.8 12.4 10.4 5.5 0.76 0.21' 10.0 2.3 0.24 O.26 93.5 24.4°
II 48.6 12.1 9.6 7.6 0.90 0.14 8.3 1.5 1.29 l.22 80.1 17.2u
III 49.0 8.0 10.7 9.0 1.13 0.25 10.4 3.7 6.44 2.05 41.3 8.6
Data are mean 1 SD.
P < 0.05 vs. grade III
P < 0.00 1 vs. grade III
P < 0.005 vs. grade III
Research Committee of Tokai University School of Medicine, and
an informed consent to open renal biopsy and in situ hybridization
studies was obtained from each patient [221. The following clinical
parameters were examined at the time of open renal biopsy: age,
known duration of diabetes, the level of serum creatinine, hemo-
globin Ale, urinary protein and 24-hour creatinine clearance.
These parameters were expressed as mean SD (Table 1).
We also examined five control samples obtained from five
subjects using uninvolved portions of surgically removed kidneys
afflicted with malignancies. After resecting, the samples were
embedded in the OCT compound (Tissue Tek; Miles Inc., Elk-
hart, IN, USA) and stored until use. These patients had no urinary
abnormalities and histopathological examination of control tis-
sues excluded any glomerular diseases.
In situ hybridization
In situ hybridization was performed according to the modified
technique developed in our laboratory [19, 20]. Briefly, fresh
kidney biopsy tissues were embedded in OCT compound and
stored at —70°C until use. Specimens were cut 4 m thick and the
sections were fixed in 4% paraformaldehyde in phosphate-buff-
ered saline; then they were deproteinized by HCI and digested
with proteinase K (Sigma Chemical Co., St. Louis, MO, USA).
The specimens were prehybridized in a prehybridization buffer,
drained and hybridized overnight with digoxigenin (DIG)-labeled
oligonucleotide probe in the prehybridization buffer. After hy-
bridization, the DIG-labeled probe was visualized by immunohis-
tochemical staining using a mouse monoclonal anti-DIG antibody
(1333062; Boehringer, Mannheim, Germany), peroxidase (HRP)-
conjugated rabbit anti-mouse antibody (Dako P260), and HRP-
conjugated swine anti-rabbit antibody (Dako P399). Color was
developed with diaminobenzidine tetrahydrochioride in 0.05 M
Tris-HC1, pH 7.6, and 0.03% H2O2. Sections were briefly coun-
terstained with hematoxylin, rinsed, dehydrated, cleared in xylene
and mounted.
To evaluate the specificity of the signals, three types of control
experiments were carried out as previously described [19, 20].
First, pre-treatment with RNase (Boehringcr Mannheim Bio-
chemica) was performed after proteinase K digestion, and there-
after sections were prehybridized and hybridized. Second, a sense
probe, complementary to the antisense probe, was reacted with
the section in place of the antisense probe. Finally, a competitive
study was performed by adding 100-fold excess amount of homol-
ogous or unrelated, unlabeled oligonucleotides to the hybridiza-
tion buffer together with the antisense probe.
Probes and labeling
We selected a 25-base sequence complementary to those of
mRNA for MMP-3 and TIMP-1, as previously described [18]. The
probe for IV-C (cr1 chain) corresponded to the sequences of No.
1047-1072 of human IV-C eDNA [23]. The sequence used in the
present study showed no significant similarity with any other
known sequences including other isoforms of IV-C deposited in
the gene data bank (GenBand Rd. 85, December 1994). One
hundred picomoles of the oligonucleotide probe were labeled
using a DIG oligonucleotide tailing kit according to the standard
protocol (Boehringer 1417—231). Free DIG was removed by
ethanol precipitation and dissolved in diethylpyrocarbonate-
treated water.
Tissue scoring
The expression of IV-C mRNA, MMP-3 mRNA and TIMP-1
mRNA was quantitated using the method described previously
[20]. Briefly, we evaluated the degree of expression of these
mRNAs in the glonieruli and interstitium by scoring the intensity
of immunoperoxidase staining, from 0( —), reflecting no staining
to 3(+++), indicating a very strong staining.
Statistical analysis
The Spearman rank correlation test was used to determine the
correlation between each mRNA expression and histological
grading. Differences between groups were analyzed for statistical
significance using analysis of variance. A P value < 0.05 denoted
the presence of a statistically significant difference between
groups.
RESULTS
The results of staining for MMP-3 mRNA and TIMP-1 mRNA
and TV-C mRNA are summarized in Table 2. Our in situ
hybridization method demonstrated cells positive for these
mRNAs in renal tissue of DN and control. As shown in Figure 2,
in situ hybridization followed by PAS staining clearly identified
individual cells positive for MMP-3 mRNA in the renal tissue of
DN. These cells included glomerular mesangial (Fig. 2b) and
epithelial cells (Fig. 2c) and cells of Bowman's capsule (Fig. 2d).
In addition, a few glomerular endothelial cells were also found to
express the mRNA (data not shown). The types of cells positive
for TIMP-1 mRNA and IV-C mRNA were similar to those for
MMP-3 mRNA (data not shown). The subcellular distribution of
signals for MMP-3, TIMP-1 and lV-C mRNAs varied from a
diffuse cytoplasmic to perinuclear granular pattern.
Figure 3 shows the expression of MMP-3, TIMP-1 and IV-C
mRNAs in diabetic glomeruli with different level of tissue injury.
Signals for these mRNAs were observed in several glomerular
cells among glomeruli of grade I (Fig. 3 a, c, e). Glonierular
expression was noted to diminish with the progression of mesan-
gial expansion in grade 11 and especially grade III (Fig. 3 h, d, f).
In glomeruli of the latter group, cells in Kimmelstiel-Wilson
b4
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Table 2. Expression of MMP-3, TIMP-1 and Tv-c mRNAs in diabetic nephropathy
Patient
no.
Histological
grade of diabetic
nephropathy
tv-c mRNA MMP-3 mRNA TIMP-1 mRNA
Glom tntGlom tnt Glom tnt
1 I +++ — +++ + +++ +
2 I ++ + ++ — +++ +
3 I +++ + +++ + +++ +
4 I ++ — ++ — ++ —
5 I +++ + +++ +++ +
6 I ++ + ++ + +++ +
7 I ++ — +++ — +++ —
8 I +++ — +++ ++ —
9 II ++ + ++ + ++ +
10 II +++ ++ + ++ +++ ++
11 II +++ ++ ++ ++ ++ ++
12 II +++ + + +++ +++ +
13 II ++ ++ ++ + ++ ++
14 II +++ ++-1- ++ ++ + +++
15 II +++ ++ ++ ++ ++ ++
16 II +++ + ++ + + +
17 III + ++ + +++ + ++
18 III + +++ + +++ + +++
19 III + +++ + ++ + +++
control i + — + — + —
control2 ++ — ++ — +++ +
control3 + + + + + —
control4 +++ + +++ + ++ +
control5 + — + — + —
Abbreviations are: Glom, glomeruli; tnt, interstitium. Signal intensities are: —, no signal; +, weak; + +, strong; + + +, very strong.
Fig. 2. In situ hybridization for MMP-3 mRNA
combined with PAS staining in glomeruli of
grade I. A high magnification view (X 1000)
showing individual cells positive for MMP-3
mRNA; mesangial cells (arrow, b), glomerular
epithelial cells (arrowheads, c) and cells of
Bowman's capsule (arrowheads, d). Note also a
mesangial cell negative for MMP-3 mRNA
(arrow, a).
nodules as well as other glomerular cells were negative for these
mRNAs (Fig. 3 b, d, f).
Table 3 summarizes the correlation between expression of these
mRNAs and histological changes in DN. Glomerular expression
of MMP-3 mRNA as well as TIMP-1 mRNA correlated inversely
with the degree of mesangial expansion (P < 0.001, P < 0.003).
Table 4 shows that the degree of IV-C mRNA expression in
glomeruli of grades I and II was significantly stronger than that of
grade III (P < 0.00 1); however, there was no significant inverse
correlation between TV-C mRNA expression and histological
grading in glomeruli (Table 3).
We also examined the expression of these mRNAs in the
interstitium. A number of tubular epithelial cells, particularly
atrophic tubules, as well as some infiltrating cells, were stained for
MMP-3 mRNA and TIMP-1 mRNA and IV-C mRNA. Figure 4a
shows a signal for MMP-3 mRNA in tubular epithelial cells in a
representative tissue sample of grade I. The expression was
stronger in atrophic tubules and infiltrating cells of grade III (Fig.
1a c c tr
Fig. 3. In situ hybridization study for MMP-3
(a and b), TIMP-1 (c and d) and IV-C (eandJ)
mRNAs in glomeruli. Sections (a) and (c), and
(b) and (d) are serial sections. Note the large
number of cells positive for MMP-3, TTMP-1
and TV-C mRNAs in the glomeruli of grade I
(a, c and e, X200). In contrast, glomerular
expression of these mRNAs is remarkably
diminished in grade III (b, d and f, ><200).
Note that almost all cells in the glomeruli of
grade TIT, including Kimmelstiel-Wilson
nodules, are negative for MMP-3, TIMP-1 and
TV-C mRNAs, while positively stained cells for
these mRNAs are evident around the
glomeruli. N, Kimmelstiel-Wilson nodule.
Table 3. Relationship between the expression of MMP-3, TIMP-1 and
IV-C mRNAs and degree of mesangial expansion and tubulointerstitial
injury
TV-C MMP-3 TTMP-1
Expression of mRNA in glomeruli —0.345 —0.812 0.722"
Expression of mRNA in interstitium 0.821a 0.841' 0.806
Glomerular expression of MMP-3 and TTMP-1 mRNAs correlated
inversely with the degree of mesangial expansion (Spearman rank test, P
<0.001, P < 0.003). Tnterstitial expression of MMP-3, TIMP-1 and TV-C
mRNAs correlated significantly with the degree of tubulointerstitial
damage (Spearman rank test, P < 0.001).P <0.001
bp <0.003
4h). As shown in Figure 4 c-f, the signals for TIMP-i and IV-C
mRNAs were also stronger in atrophic tubules and infiltrating
cells in the interstitium of grade III compared with grade I.
Interstitial injury, evident by the presence of widespread intersti-
tial fibrosis, tubular atrophy and a large number of infiltrating
cells, was present in grade II and especially grade III. The
interstitial expression of MMP-3 mRNA, TIMP-1 mRNA as well
as TV-C mRNA was proportionate with the severity of interstitial
damage (Table 3; P < 0.001).
To verify the specificity of the signal obtained in the in situ
hybridization study, three control studies were performed. Figure
4g shows a competitive experiment where a 100-fold excess
amount of unlabeled homologous oligonucleotide was added to
the standard hybridization mixture containing MMP-3 labeled
probe. The signal of each mRNA disappeared when a large
amount of unlabeled homologous oligonucleotide was added. In
contrast, the addition of nonhomologous oligonucleotide did not
block the signal (data not shown). Pretreatment of tissue with
RNase prior to hybridization eliminated most of the signal
obtained with the MMP-3 probe (Fig. 4h). In other studies, that is,
hybridization with a MMP-3 sense probe and the same three
control experiments for verifying the specificity of TIMP-1 and
TV-C probes, no signal was demonstrated for these mRNAs (data
not shown).
Finally, the expression of MMP-3, TIMP-1 and TV-C mRNAs
did not correlate significantly with any clinical parameters includ-
ing age, known duration of diabetes, the level of serum creatinine,
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Table 4. Comparison of mRNA expression among three grades by analysis of variance
Histological
grade of diabetic
nephropathy
TV-C mRNA MMP-3 mRNA TIMP-1 mRNA
Glom Tnt Glom Tnt Glom Tnt
I 2.50 0.54a 0.50 0.54' 2.63 0.52 0.38 0.52 2.75 0.46 0.63 0.52'
II 2.75 0.47a 1.75 0.71C 1.75 0.46C 1.75 0.71C 2.00 0.76C 1.75 0.71c
III 1.00 0.00 2.67 0.58 1.00 0.00 2.67 0.58 1.00 0.00 2.67 0.58
Data are mean 1 so. Abbreviations are: Glom, glomeruli; Tnt, interstitium.
aP < 0.001 vs. grade III
h P < 0.005 vs. grade II
P < 0.005 vs. grade III
d P < 0.001 vs. grade II
P < 0.05 vs. grade II
hemoglobin Ale, urinary protein, and 24-hour creatinine clear-
ance.
DISCUSSION
The major findings of the present study were the expression of
TV-C mRNA, MMP-3 mRNA and TIMP-1 mRNA in the glomer-
uli and interstitium and the association of such expression with the
severity of histological changes in DN.
Recent developments in cellular and molecular biology have
allowed a better understanding of ECM production and degrada-
tion in renal diseases. Cultured mesangial and glomerular epithe-
hal cells are able to synthesize not only ECM, but also MMPs and
TIMPs [14, 24—271. To our knowledge, the present study is the
first report demonstrating simultaneous expression of TV-C
mRNA, MMP-3 mRNA and TIMP-1 mRNA in human DN. In
order to distinguish individual cells positive for each mRNA in the
glomeruli, we performed PAS staining after in situ hybridization
and then defined the topographical relationship of positively
stained cells relative to GBM and mesangial matrix. Signals for
TV-C mRNA, MMP-3 mRNA and TIMP-1 mRNA were present
among glomerular resident cells, including glomerular mesangial,
epithelial and endothelial cells and cells of Bowman's capsule, as
well as in tubular epithelial cells and infiltrating cells in the
interstitium. In contrast to our findings that all glomerular cell
types can synthesize al of Tv-C as well as MMP-3 and TIMP-1,
Lee, Pollock and Lovett [281 examined the glomeruli of normal
rats by the in situ reverse transcription technique and demon-
strated that the source of al chain of Tv-C transcript was only
glomerular endothelial cells. The discrepancy between the two
studies allows us to postulate that heterogeneity for IV-C synthe-
sis exists in glomerular cells under normal physiological condi-
tions, but in the diabetic kidney all glomerular cells are capable of
producing TV-C. However, the underlying mechanisms causing
this change are not well understood. Further studies are necessary
to characterize the role of each glomerular cell in the progression
of glomeruloscierosis.
A balance between production and degradation of ECM may
be critical during ECM expansion in glomeruli [29]. Increased
collagen synthesis may be an important factor in the pathogenesis
of DN [30]. Several in vitro studies have demonstrated overpro-
duction of TV-C by mesangial cells and other cells in the presence
of high concentration of glucose [9—11]. Furthermore, the mRNA
level for IV-C is significantly increased in isolated glomeruli of
diabetic rat [31] and in cortical kidney of diabetic mouse [32].
However, the present study showed that the expression of lv-C
mRNA tended to correlate inversely with the degree of mesangial
expansion in DN. The discrepancy between human studies and
experimental model suggest that glomerular synthesis of IV-C
increases during the early to middle phase of mesangial expansion
in human DN. Moreover, the results of short-term in vitro studies
may not always correspond with the long-term situation in vivo. In
fact, both mesangial cells cultured for a long period and mesangial
cells cultured on glycated matrix showed a reduced production of
collagen [33].
Immunohistological analysis of IV-C protein is important for
determinant of the net effect on IV-C accumulation, because
transcripted mRNA is not always translated to the protein.
Several reports have shown that the level of IV-C protein
increases in parallel with the progression of DN [5, 34]. However,
using immunofluorescence analysis and specific antibodies against
alto a4 isoforms of IV-C, Yagame et a! [35] recently showed that
the intensity of staining of al chain of TV-C tended to decrease
with deteriorating histological features in NIDDM patients with
DN. Altogether, these results suggest that the expression of both
mRNA and protein of al chain of IV-C may be diminished in the
glomeruli of DN. Since the previous studies [35, 36] indicated that
a site-specific alteration of ECM synthesis may occur in diabetic
glomeruli and that other isoforms of IV-C are also involved in the
progression of DN, further studies on the ECM production are
necessary for a better understanding of the pathogenesis of DN.
Several investigators have examined MMP activity in the dia-
betic rat model. Reckeihoff et a! [37] reported that glomerular
metalloproteinase activity is decreased in the diabetic rats and
Nakamura et a! [38] demonstrated diminishing levels of MMP-3
with age in glomeruli of streptozotocin-induced diabetic rats.
Furthermore, the turnover rate of collagen was also found to
decrease in the same rat model [39, 40]. The present experiment
also showed that the expression of MMP-3 mRNA declined with
the progression of mesangial expansion. Considered together,
these results suggest that reduced activity of glomerular MMP-3
may contribute to accumulation of ECM and mesangial expansion
in DN.
In the present study, the expression of TIMP-l mRNA was
parallel to that of MMP-3 mRNA. In contrast, the level of mRNA
for TIMP-l increases while that for MMP-3 significantly de-
creases with age in streptozotocin-induced diabetic rats [381. The
high level of TIMP-1 and low MMP mRNA easily explain
mesangia! expansion in the diabetic model. The reason for the
discrepancy between human and animal model studies remains
unclear. It is probable that a complex relationship may exist
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Fig. 4. In situ hybridization for MMP-3 (a and
b), TIMP-1 (c and d) and 1V-C (e and J)
mRNAs in the tubulointerstitium of diabetic
nephropathy and control studies to ventS' the
specificity of the signal (g and h). (a) Note two
tubules positively stained for MMP-3 mRNA in
grade I (arrows, X200). (b) Many atrophic
tubules and infiltrating cells have a strong
expression of MMP-3 mRNA in grade III
(x100). (c and d) Note the occasional staining
of tubular epithelial cells for TIMP-1 mRNA in
grade I (c, x 100), while increased expression of
the mRNA is evident in the severely damaged
tubulointerstitium of grade III (d, X 100). (e
and f) Strong expression of TV-C mRNA in the
tubulointerstitium of grade III (f, >( 200)
compared with that of grade I (e, X200). (g)
Competitive study to verify the signal specificity
(X200). A Section is hybridized with MMP-3
antisense probe and a 100-fold excess amount
of unlabeled homologous oligonucleotide. No
signal is observed in the section. (h) RNase
treatment of the section before hybridization
with probe abolishes the signal for MMP-3
mRNA. Note that only nuclei of the tubules are
weakly stained with hematoxylin (X400).
between TIMP-1 and MMP-3 in human DN. Admittedly, the
number of patients examined in our study was too small to allow
firm conclusions regarding the association between TV-C, MMP-3
and TIMP-1 mRNAs expression in DN. Further studies are
required for a better understanding of the balance between
MMP-3 and TIMP-1 in this form of nephropathy.
Is the expression of MMP-3 mRNA or TIMP-1 mRNA differ-
ent in different renal diseases? We recently reported the localiza-
tion of MMP-3 mRNA and TIMP-1 mRNA in IgA nephropalhy
[18]. The results of that study showed that these mRNAs are
weakly expressed in glomeruli of mild lesions and, conversely, they
were strongly expressed in glomeruli of severely damaged IgAN
tissue. The diverse expression of MMP-3 mRNA and TIMP-l
mRNA in DN and IgAN may reflect different pathogenic mech-
anism of these two renal diseases, IgAN is considered to be an
immune-mediated chronic glomerulonephritis [41, 42], whereas
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the long-term hyperglycemia is considered to play an important
role in the pathogenesis of DN. Recently, it has been reported
that advanced glycosylation end products (AGEs), which are
non-enzymatically glycated protein, play an important role in the
pathogenesis of diabetic complications [43—45]. In this regard, we
recently reported the presence of AGEs in renal biopsy specimens
of patients with DN [461. AGEs were prominent in glomeruli but
not in the interstitium, except for vascular walls. The existence of
AGEs in diabetic glomeruli may explain the different expression
of MMP-3 and TIMP-1 mRNAs in glomeruli between IgAN and
DN. Furthermore, AGEs stimulate matrix production and inhibit
mesangial proliferation [47], and glycated GBM is more resistant
to digestion by protease [41]. Considered together, we believe that
different pathogenic processes may result in different levels of
expression of MMP-3 and TIMP-1, and that these enzymes may
play different roles in mesangial expansion in DN and IgAN.
Our results also demonstrated that the expression of MMP-3
mRNA and TIMP-1 mRNA increased in the interstitium with the
progression of interstitial injury in DN, resembling that reported
in IgAN [18]. This related behavior of expression suggests that
MMP-3 and T1MP-l play a similar role in the progression of
interstitial damage in DN and IgAN, and that the interstitial
injury may progress through a common pathway. When consid-
ered in conjunction with increased expression of IV-C mRNA in
the severely damaged interstitium of DN, the enhanced expres-
sion of IV-C and TIMP-1 may lead to an accumulation of ECM
and interstitial injury in DN. Furthermore, the fact that the
expression of these mRNAs correlated positively with the severity
of interstitial injury but negatively with that of glomerular lesion
may support the importance of the interstitium in the progression
of renal disease [48, 49]. With regard to the involvement of other
types of collagen, it has been recently reported that the expression
of interstitial type collagen I plays a major role in the development
of renal interstitial fibrosis [50, 51]. Further studies examining the
expression of other types of collagen are warranted to clarify the
mechanisms of interstitial fibrosis in human renal diseases.
In conclusion, human renal tissue samples from patients with
DN expressed IV-C mRNA, MMP-3 mRNA and TIMP-1 mRNA
in glomerular mesangial, epithelial and endothelial cells and cells
of Bowman's capsule in the glomeruli and some tubular epithelial
and infiltrating cells in the interstitium using DIG-labeled in situ
hybridization. The expression changed with the progression of
mesangial expansion and interstitial injury. Our results suggested
that alteration of ECM production and degradation is associated
with the pathogenesis of DN.
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